OOIR: Observatory of International Research

Papers

(The median citation count of Pediatric Blood & Cancer is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Glomerular filtration rate in children and young adults with haemato‐oncological disease and infection is best described by three‐compartment iohexol model	69
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	47
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	41
	37
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know	36
	35
Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience	33
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma	33
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	32
Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment	32
A randomized double‐blind placebo‐controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer	31
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia	31
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	29
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy	28
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements	27
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort	25
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor	25
Choriocarcinoma in neonates and infants: A severe but curable disease	25
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	25
Social determinants of neurocognitive and academic performance in sickle cell disease	24
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy	24
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant	24
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome	23
Prognostic factors of sepsis in children with acute leukemia admitted to the pediatric intensive care unit	23
	22

Response assessment by positron emission tomography‐computed tomography as compared with contrast‐enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low	22
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213	22
How we approach complex vascular anomalies and overgrowth syndromes	22
Ultrastructural investigation on pseudo Chediak–Higashi abnormality in acute lymphoblastic leukemia: A case report	22
KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up	21
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research	21
Luspatercept for non‐deletional hemoglobin H disease	20
Cabozantinib in children with recurrent diffuse gliomas	20
Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study	20
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes	20
Late‐onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma	20
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial	20
Association of language proficiency, sociodemographics, and neurocognitive functioning in dual‐language Latino survivors of childhood acute lymphoblastic leukemia and lymphoma	19
Bloodletting as Medical Child Abuse Revealed by Lack of Iron Accumulation Despite Multiple Erythrocyte Transfusions	19
Metastatic and multiply relapsed SDH‐deficient GIST and paraganglioma displays clinical response to combined poly ADP‐ribose polymerase inhibition and temozolomide	19
High‐dose carboplatin–irinotecan–temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma	19
Implementation of physical rehabilitation programs for children with cancer across low‐ and middle‐income countries: A need of the hour perspective	19
Durable changes in the gut microbiome in survivors of childhood acute lymphoblastic leukemia	19
Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study	18
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Reg	18
Palliative care and suicidality: Complicated conversations at two ends of the spectrum	18
Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States	18
A community‐based trial of a psychosocial eHealth intervention for parents of children with cancer	18
Kaposiform hemangioendothelioma of the bone in children and adolescents	18
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities	18
Strategies for the Treatment of Desmoplastic Small Round Cell Tumor: A Case Series	18
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?	17
Role of anticoagulation in the management of tumor thrombus: A 10‐year single‐center experience	17
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States	17
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors	17
After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?	17
The Ukrainian children emergency: How the Pediatric Oncology Unit of Turin supports cancer patients and their families who have escaped war	17
Benchmarks for Psychosocial Staffing in Pediatric Oncology: Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care (iSTEPPP) Study	17
No wrong decisions in an all‐wrong situation. A qualitative study on the lived experiences of families of children with diffuse intrinsic pontine glioma	16
Mesial temporal pilocytic astrocytoma compressing brainstem: Clinical cure after stereotactically inserted Ommaya and radiosurgery‐induced shrinkage	16
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition	16
Automating the treatment planning process for 3D‐conformal pediatric craniospinal irradiation therapy	16
	16
Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children	16
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	16
Variant histology of pediatric nodular lymphocyte‐predominant Hodgkin lymphoma with IgD and CD30 expression	16
Successful Erwinia asparaginase one‐bag rapid desensitization process in a pediatric patient with acute lymphoblastic leukemia	15
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion‐dependent non‐dominant hereditary spherocytosis due to homozygous SPTA1 mutation	15
How we approach coagulopathy with vascular anomalies	15
A strategic approach to integration of spiritual care into the standards for the psychosocial care of children with cancer and their families	15
Platelet transfusions in neonates—Unresolved aspects and future directions	15
B‐cell lymphoblastic leukemia in an adolescent with Dravet syndrome	15
Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30⁺ lymphoproliferative disorder: A case report	15
	15
Abnormal coronary hyperperfusion due to a giant hemangioendothelioma in fetal distress: A case report	14

A qualitative exploration of parental caregivers’ experience caring for children who have survived medulloblastoma	14
Implementation science in pediatric oncology: A narrative review and future directions	14
In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consor	14
Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic‐derived T‐cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency	14
Shifting perspectives and transformative change: Parent perspectives of an active music engagement intervention for themselves and their child with cancer	14
Case report: Dichloroacetate‐induced methaemoglobinaemia in a G6PD‐deficient neonate	14
Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma	14
Ring sideroblasts and macrocytic anemia in an infant: Clues to the diagnosis of Pearson syndrome	14
Concurrent carcinocythemia, chest wall and right knee joint involvement in Ewing sarcoma	14
Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality	13
Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder	13
Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–b	13
Staging childhood cancers in Europe: Application of the Toronto stage principles for neuroblastoma and Wilms tumour. The JARC pilot study	13
Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon	13
CIC–NUTM1 sarcoma in an 8‐year‐old female patient with a new fusion: A case report	13
Incidence and survival for childhood cancer by endorsed non‐stage prognostic indicators in Australia	13
Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec	13
ε‐Aminocaproic acid versus tranexamic acid in children undergoing complex cranial vault reconstruction for repair of craniosynostosis	13
A proposed algorithm for evaluation and management of pediatric hemophilia patients who present to the emergency department with head trauma	13
Uniting for Change: The GLOW Initiative and Its Impact on Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	12
Diagnosis, monitoring, and management of pyruvate kinase deficiency in children	12
Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey	12
SNAP: Supportive non‐invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team	12
Dyadic coping experiences of parents of children with vascular anomalies	12
Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer	12
Posterior Mediastinal Tumor Presenting with Compressive Myelopathy: Uncommon Site for a Rare Tumor	12
Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)	12
Paraneoplastic Ichthyosis Preceding the Diagnosis of Gluteal Rhabdomyosarcoma at Initial Presentation and Relapse	12
Correction to: Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia	12
Epidemiology of clinically unsuspected venous thromboembolism in children with cancer: A population‐based study from Maritimes, Canada	12
Stomatocytes, a whistleblower for future familial cardiovascular events: Unraveling the diagnosis of sitosterolemia in an Indian family	12
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation	12
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma	12
Transient leukopenia, thrombocytopenia, and severe neutropenia associated with acute SARS‐CoV‐2 infection	12
Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States	12
The Role of Perceived Health‐Related Information Adequacy in the Experiences of Parents of Children With Complex Vascular Anomalies	12
Corrigendum	12
Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An ¹⁸F‐DOPA PET study	12
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol	12
Age‐ and sex‐specific rates of gall bladder disease in children with sickle cell disease	12
Assessment of Caregivers and Their Children With Cancer Regarding Information Provided by Healthcare Teams: Advancing Stages Toward the Creation of a Structured Education Program at the National Level	12
Intraventricular topotecan in the successful treatment of recurrent CNS pleuropulmonary blastoma	11
Location of death and hospice use in children with cancer varies by type of health insurance	11
Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient	11
Astrovirus VA1/HMO encephalitis after allogeneic hematopoietic cell transplantation: Significant role of immune competence in virus control	11
Diminished ovarian reserve in adolescent cancer survivors treated with heavy metal chemotherapy	11
Unraveling Juvenile Hyaline Fibromatosis: A Case of Novel ANTXR2 Mutations Associated with Subcutaneous Masses and Hydronephrosis	11
Novel ELANE mutation causing severe congenital neutropenia with unpredictable fluctuations in neutrophil counts	11
Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment	11
Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus	11
Abstracts from the 39^th Annual Meeting of the Histiocyte Society	11
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol	11
Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy	11
Radiogenomics prediction for MYCN amplification in neuroblastoma: A hypothesis generating study	11
	11
Prevalence of neuropathic pain in adolescents with sickle cell disease: A single‐center experience	11
Issue Information	11
Wiskott–Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India	11
Acute exacerbation of graft‐versus‐host disease following SARS‐CoV2 infection after hematopoietic stem cell transplant in two pediatric patients	11
Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831	11
Poor prognosis of B‐cell acute lymphoblastic leukemia with TCF/PBX1 fusion gene and ovarian involvement at diagnosis: Two case reports and review of the literature	11
How we approach genetics in the diagnosis and management of vascular anomalies	11
Issue Information	11
Pediatric Mixed Phenotype Acute Leukemia With ETV6::ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation	11
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity	11
Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries	11
Parental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross‐Sectional Study	11
Familial hemophagocytic lymphohistiocytosis onset as central diabetes insipidus in a child	11
Cyclin D2 gene variance and expression level in pediatric acute lymphoblastic leukemia	11
Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations	10
Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series	10
Surgical aspects and outcomes after nephrectomy for Wilms tumour in sub‐Saharan Africa: A report from Wilms Africa Phase II—CANCaRe Africa	10
Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma.”	10
Contemporary surgical management of pediatric non‐rhabdomyosarcoma soft tissue sarcoma	10
De novo antiphospholipid antibody syndrome in two infants	10
Provision of a personalized survivorship care plan and its impact on cancer‐related health literacy among childhood cancer survivors in Hong Kong	10
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia	10
Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies	10
Modern surgical strategies in pediatric neuroblastoma: Evolving approaches and treatment principles	10
FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features	10

Complete response of metastatic alveolar soft part sarcoma in an adolescent female treated by combined immune checkpoint inhibitors	10
Pediatric refractory immune thrombocytopenia: A systematic review	10
SARS‐CoV‐2 vaccine acceptability among caregivers of childhood cancer survivors	10
Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience	10
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients	10
Comparison of transfusion reactions in children and adults: A systematic review and meta‐analysis	10
Atypical presentations of RECQL4‐related syndromes	10
Diagnostic accuracy of image‐guided core needle biopsy of non‐central nervous system tumors in children	10
Erratum	10
How we approach lymphedema in the pediatric population	10
Addition of arm anthropometry to body mass index for age, but not serum albumin, improves the accuracy of the nutritional assessment in severely and moderately malnourished children with cancer	10
Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials	10
Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison	10
Blood counts in children with Down syndrome	10
Chemotherapy‐induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care	10
Cancer does not wait: Safeguarding care for pediatric acute lymphoblastic leukemia patients during the COVID‐19 pandemic in a Mexican hospital	10
Cutaneous adverse events in children treated with vemurafenib for refractory BRAF^V600E mutated Langerhans cell histiocytosis	10
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma	10
Clinic reported facilitators and barriers to pediatric cancer survivor care delivery among survivorship clinics: A fishbone analysis	10
Philadelphia chromosome‐like B‐acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation	10
Successful hematopoietic stem cell transplantation in MYH9‐related congenital thrombocytopenia	10
Time to diagnosis among young patients with cancer	9
Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease	9
Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study	9
Challenge implementing Pediatric Early Warning Systems to improve early identification of clinical deterioration in hospitalized children with cancer: Is it the score?	9
Socioeconomic Factors Associated With Participation in Postmortem Tissue Donation in Pediatric Central Nervous System Tumors	9
Pulmonary hypertension screening in children with sickle cell disease	9
The quality and content analysis of YouTube videos about chemotherapy for children	9
Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group	9
Daratumumab‐induced minimal residual disease negative remission in CD38 (dim)‐positive pediatric acute myeloid leukemia	9
Comment on “Comparison of hypersensitivity rates to intravenous and intramuscular PEGasparaginase in children with acute lymphoblastic leukemia: A meta‐analysis and systematic review”	9
New therapeutics for children with sickle cell disease: A time for celebration, caution, or both?	9
Introduction to fertility preservation in pediatric patients with cancer: A report from the Children's Oncology Group	9
An SRF‐rearranged malignant cellular myoid neoplasm with a novel SRF–MKL2 fusion	9
Pneumatosis intestinalis in the pediatric oncology population: An 11‐year retrospective review at Memorial Sloan Kettering Cancer Center	9
Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group	9
The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer	9
Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)	9
Use of milrinone to support therapy‐induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high‐risk FLT3+ acute myeloid leukemia	9
Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels	9
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series	9
A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromes	9
Coagulopathy and related complications following sclerotherapy of congenital venous malformations	9
Recurrent thrombosis with a mispositioned stent after treatment of an adolescent with May–Thurner syndrome	9
EZH2 is a key component of hepatoblastoma tumor cell growth	9
Pre‐transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients	9
Associations between Medicaid enrollment and diagnosis stage and survival among pediatric cancer patients	9
Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR	9
Differences in characteristics of children with cancer who receive standard versus concurrent hospice care	9
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three‐fold volume increase without life‐ or organ‐threatening features	9
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial	9
Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents	9
Continuous blood purification successfully treated severe cytokine release syndrome and immune effector cell‐associated neurotoxicity syndrome after chimeric antigen receptor T‐cell therapy: A case re	9
Pediatric cancer care in Africa: SIOP Global Mapping process	9
Efficacy of ready‐to‐use therapeutic food in malnourished children with cancer: Results of a randomized, open‐label phase 3 trial	9
Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial	9
Thalidomide‐associated autoimmune hemolytic anemia	9
Comment on: Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019. Emerging therapeutic options for sickle cell anemia	9
Impact of magnetic resonance angiography parameters on stroke prevention therapy in pediatric patients with sickle cell anemia	9
Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes	9
Neuroblastoma with neonatal cardiogenic shock and multiple‐organ failure: A rare association	9
Strategies to improve communication about neurocognitive impacts in pediatric oncology: Quality improvement findings	8
Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant	8
NTRK2 gene fusion and resistance mutation: Seventeen‐year course of a paediatric glioma	8
Can virtual care reduce treatment burden in pediatric leukemia? A retrospective cost analysis	8
	8
Circumcision bleeding rates in patients diagnosed with delta‐storage pool deficiency later in life	8
A nomogram model to predict prognosis of patients with hepatoblastoma	8
Risk factors for parental divorce in children with cancer	8
Pediatric severe factor XI deficiency: A multicenter study	8
The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study	8
Hyperthyroidism following transplantation and SARS‐CoV‐2 exposure	8
Hodgkin lymphoma involving the sternum	8
A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony‐stimulating factor	8
Bilirubin crystals in neutrophils of a newborn with Rh incompatibility	8
Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark	8
	8
Trends of lymph node sampling and metastasis in pediatric and young adult patients with clear cell, epithelioid, and synovial sarcomas	8
Acute Liver Failure in a 17‐Year‐Old Boy Caused by a Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel MYB Rearrangement	8
Current approaches to management of bone sarcoma in adolescent and young adult patients	8
Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy	8
A success story of an infantile anaplastic large cell lymphoma: A case report	8
Comment on: Patients with nonmetastatic embryonal rhabdomyosarcoma arising in the biliary tract should be treated on low‐risk clinical trials	8
Myelodysplastic syndrome in a patient with Barth syndrome (3‐methylglutaconic aciduria type II)	8
Can you hear me now? Tools for cultivating a culture of respect, value, and appreciation within pediatric hematology, oncology, and cellular therapy	8
Reply to: Comment on: Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma	8
	8
“I was very scared when I found out my son had sickle cell”: Caregiver knowledge and attitudes toward early intervention for young children with sickle cell disease: Implications for policy and practi	8
Feasibility of a prospective physiotherapy model of care during the intense treatment phase of childhood cancer (FITChild): A mixed methods design	8
	8
Effects of COVID‐19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia	8
Diagnosis and management of isolated neutropenia: A survey of pediatric hematologist oncologists	8
Malignant extracranial germ cell tumours: A first national report by the South African Children's Cancer Study Group	8
Successful administration of CD19 chimeric antigen receptor T cells in association with severe cyanotic congenital heart disease	8
“Per protocol” practice patterns for Children's Oncology Group trials within the radiation oncology community	7